期刊文献+

LMP2混合肽负载树突状细胞与EB病毒感染患者外周血单个核细胞共培养产生识别EB病毒抗原的T细胞 被引量:2

T Cells Recognizing EBV-epitopes Arose in Co-culture of Peripheral Blood Mononuclear Cells from EB-infected Patients and Dendritic Cells Loaded with LMP2-mixed Peptides
下载PDF
导出
摘要 LMP2是EB病毒感染细胞后表达的一种蛋白。本研究探讨应用适于不同HLA分型的EB病毒-LMP2抗原混合肽(MIX-LMP2)体外刺激EB病毒感染患者外周血单个核细胞,诱导产生EB病毒抗原特异性的细胞毒性T淋巴细胞(CTL)。取EB病毒相关噬血细胞综合症患者的外周血,分离并诱导培养树突状细胞,在培养过程中用EB病毒MIX-LMP2混合肽刺激,促成熟后在体外激活自体T淋巴细胞,每周刺激1次,共刺激2次;同时对部分分离的淋巴细胞在培养过程中不予以刺激作为对照。用基因扫描T细胞受体(TCR)β基因图谱的方法观察培养前后的T细胞克隆分布变化;用流式细胞术检测T淋巴细胞的表型变化;将培养的细胞和靶细胞共培养检测IFN-γ的分泌以研究CTL细胞抗原特异性的细胞毒作用。研究结果表明,基因扫描TCRβ基因结果显示体外培养改变了患者的TCRβ基因图谱,培养前为寡克隆的TCRβ基因家族在培养后出现与正常人相似的多峰分布,提示淋巴细胞亚群分布恢复正常;流式细胞分析显示培养前的淋巴细胞CD3+、CD3+CD8+、CD3+CD45RA-CD45RO+比例分别为70.73%、42.99%、27.56%,用负载EB病毒LMP2肽2次刺激体外培养后,上述的淋巴细胞表型分别升高为95.17%、52.54%、81.41%。NK细胞(CD3-CD56+)、调节性T细胞(CD4+CD25+FOXP3+)比例变化不大,分别从培养前的2.12%,0.03%变化为2.35%,0.02%。CD3+CD45RA-CD45RO+细胞增长比例较大,表明2次刺激后大部分的初始型T淋巴细胞被激活。IFN-γ分泌检测结果显示,当负载LMP2肽的DC细胞作为靶细胞时,刺激1次的细胞分泌IFN-γ量和刺激2次的细胞分泌IFN-γ量明显高于同期未刺激细胞分泌IFN-γ量(p<0.05)。而对于未负载LMP2的DC细胞作为靶细胞时,IFN-γ检测结果则显示无统计学意义(p>0.05)。结论:用负载EB病毒MIX-LMP2肽的树突状细胞(DC)刺激T淋巴细胞的培养方法,可以改变患者T淋巴细胞克隆分布,产生识别EB病毒的特异性T淋巴细胞。 The latent membrane protein 2 (LMP2) is a kind of protein expressed by EBV-infected cells. This study was aimed to investigate whether the stimulation of peripheral blood mononuclear cells with peptides induces EBV- specific cytotoxic T lymphocytes (CTL) . The peptides were mixture of LMP2 protein and available for people with different HLA types. Peripheral blood sample was collected from a patient with EBV-associated hemophagocytic syndrome. The mononuclear cells were isolated and cultured to obtain dendritic cells (DCs). Immature DCs were pulsed with MIX-LMP2 and added with different maturation-promoting factors. The auto-T lymphocytes were stimulated weekly with the harvested mature DCs loaded with MIX-LMP2, and totally for two times. Part of isolated lymphocytes was cultured without any stimulation as control. T-cell receptor (TCR) 13 spectratyping was used to analyze the distribution of different T cell subgroups before and after culture. The phenotype of T lymphocytes was determined by flow cytometry. The IFN-γ assay was used to estimate specific cytoxic activity of the cultured T cells. The results showed that the distribution of TCRβ was changed according to analysis of TCR spectratypes. From the distribution of gene families of TCRβ,the T lymphocytes were oligoclonal before culture, but shifted to a polyclonal after culture in vitro like the normalization of TCR diversity, suggesting the subgroups of lymphocyte could return to normal. The percentage of CD3 ^+ , CD3 +CD8 ^+ CD3 ^+ CD45RA^- CD45 RO^+ on T lymphocytes from freshly isolated mononuclear cells were 70.73%, 42.99%, 27.56% respectively. After being stimulated twice with DC loaded with MIX-LMP2, they further increased to 95.17%, 52.54% and 81.41%. The percentages of CD3^- CD56 ^+ NK cells and CD4 ^+ CD35 ^+ FOXP3 ^+ regulation T cells seldom changed, from 2. 12%, 0.03% to 2. 35%, 0.02% respectively. The increase of CD3 ^+ CD45RA^- CD45RO ^+ cells obviously indicated that most naive T cells could be activated. ELISA for IFN-γ showed that when DCs loaded with LMP2 peptide were used as target cells, IFN-γ level secreted by the T cells stimulated with LMP2 peptide- pulsed DCs was 805 ± 16 pg/ml and 1729 ± 49 pg/ml, the IFN-γ level secreted by T cells stimulated twicely with LMP2 peptide-pulsed DCs was 956± 23 pg/ml and 2325 ± 58 pg/ml respectively at effector-target ratios of 10: 1 and 10: 2. They were both significantly higher than that secreted by T cells without any stimulation (441 ±27 pg/m and 557 ± 19 pg/ml) (p 〈0.05). But DCs unpulsed with LMP2 peptide were used as target cells, there were no significant differences between the T cells stimulated with LMP2 peptide-pulsed DCs and the T cells without stimulation (p 〉 0.05 ). It is concluded that the antigen specific T cells recognizing EBV epitopes can be obtained by using DCs pulsed with MIX-LMP2 peptide in vitro, meanwhile the distribution of T cell subgroups can be changed and normalized.
出处 《中国实验血液学杂志》 CAS CSCD 2008年第2期392-396,共5页 Journal of Experimental Hematology
基金 国家科技部国际科技合作重大项目,编号2006DFB31430 国家自然科学基金,编号30470939资助
关键词 LMP2混合肽 树突状细胞 EB病毒感染 外周血单个核细胞 EB病毒抗原 T淋巴细胞 T lymphocyte LMP2 mixed peptide dentritic cell EBV infection PBMNC EBV epitop
  • 相关文献

参考文献9

  • 1Heslop HE, Savoldo B, Rooney CM, et al. Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease. Best Prac Res Clin Haematol, 2004;17:401 -413
  • 2Su Z, Peluso MV, Raffegerst SH, et al. The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr vires-positive Hodgkin's disease. Eur J lmmunol, 2001 ;31 : 947 -958
  • 3Lin CL, Lo WF, Lee TH, et al. Immunization with Epstein-Barr Virus (EBV) pepfide-pulsed dendritic cells induces functional CD8^+ T-cell immunity and may lead to tumor regression in patients with EBV-posidve nasopharyngeal carcinoma. Cancer Res, 2002 ;62:6952 - 6958
  • 4Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med, 2006 ;38:20 - 31
  • 5欧媛,朱平,朱霞,顾江英,刘静,杜金伟,张英,刘红星,庄昕.抗磷脂综合征识别相关抗原的T细胞克隆受体分析[J].中国实验血液学杂志,2006,14(6):1156-1159. 被引量:2
  • 6Ishii E, Ohga S, Imashuku S, et al. Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences. Crit Rev Oncol Hematol, 2005 ;53:209 -222
  • 7Griffioen M, Esther van Egmond HM, Menno AWG, et al. T cell receptor gene transfer to virus-specific t cells for cellular anti-tumor immunotherapy. Blood (ASH Annual Meeting Abstracts), 2007; 110 : 2594
  • 8Hasan A, Kollen WJ, Selvakumar A, et al. A panel of artificial antigen-presenting cells (AAPC) expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both subdominant and dominant viral epitopes for adoptive therapy. Blood (ASH Annual Meeting Abstracts), 2007; 110:2589
  • 9Borelli G, Aarvak T, Brunsvig A, et al. Optimizing culture conditions for ex vivo expansion of virus specific T cells. Blood ( ASH Annual Meeting Abstracts), 2007 ; 110 : 4863

二级参考文献8

共引文献1

同被引文献15

  • 1遗传因素、环境因素及EB病毒在鼻咽癌发生中作用的研究[J].中国肿瘤,1995,4(3):24-25. 被引量:5
  • 2毕胜利.CD45RA/CD45RO研究进展[J].中国实验诊断学,2007,11(4):561-564. 被引量:9
  • 3Radfar S, Wang Y, Khong HT. Activated CD4 ^+ T ceUs dramatically enhance chemotherapeutic tumor responses in vitro and in vivo. J Immunol, 2009; 183(10) :6800 -6807.
  • 4Joshi PS, Liu JQ, Wang Y, et al. Cytokine-induced killer T cells kill immature dendritic cells by TCR-independent and perforindependent mechanisms. J Leukoc Biol, 2006 ;80(6) :1345 -1353.
  • 5Li H, Wang C, Yu J, et al. Dendritic cell-activated cytokineinduced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery. Cytotherapy, 2009 ;11 (8) :1076 - 1083.
  • 6Xu JJ, Yao K, Yu CJ, et al. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells. Auris Nasus Larynx, 2006 ;33 (4) :441 - 446.
  • 7Wang Q, Liu HX, Zhang X, et al. High doses of mother's lymphocyte infusion to treat EBV-positive T cell lymphoproliferative disorders in childhood. Blood, 2009 ; 116 ( 26 ) : 5941 - 5947.
  • 8Kim YM, Jung MH, Song HY, et al. Ex vivo expansion of human umbilical cord blood-derived T-lymphocytes with homologous cord blood plasma. Tohoku J Exp Med, 2005 ;205 ( 2 ) : 115 - 122.
  • 9Chen HW, Liao CH, Ying C, et al. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4 ~ T cells with anti- CD3/CD28, interleukin-7, and interleukin-15 : potential for adoptive T cell immunotherapy. Clin Immunol, 2006;119 (1) :21 -31.
  • 10Lee HE, Chae SW, Lee YJ, et al. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer, 2008 ;99(10) : 1704 - 1711.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部